Posterior reversible encephalopathy syndrome (PRES): Another imaging manifestation of COVID-19.
Interdiscip Neurosurg
; 22: 100808, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-643652
ABSTRACT
Neuroimaging manifestations of COVID-19 are being reported with increasing frequency with recent reports of associated atypical leukoencephalopathies. We add to this literature by describing a COVID-19 + patient who demonstrated imaging findings typical for posterior reversible encephalopathy syndrome (PRES). The inflammatory syndrome associated with novel corona virus infection has shown markedly increased levels of cytokines and inflammatory markers. This has also been described in a proposed mechanism for PRES, where elevated inflammatory markers result in endothelial injury causing interstitial fluid extravasation typical of PRES. We expect that other cases of PRES will be observed in this population given the scope of the Covid-19 pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Journal:
Interdiscip Neurosurg
Year:
2020
Document Type:
Article
Affiliation country:
J.inat.2020.100808
Similar
MEDLINE
...
LILACS
LIS